[go: up one dir, main page]

ES8206975A1 - Procedimiento para la produccion de un preparado, practica- mente seguro frente a hepatitis,de los factores de coagula- cion de sange ix y-o x. - Google Patents

Procedimiento para la produccion de un preparado, practica- mente seguro frente a hepatitis,de los factores de coagula- cion de sange ix y-o x.

Info

Publication number
ES8206975A1
ES8206975A1 ES507400A ES507400A ES8206975A1 ES 8206975 A1 ES8206975 A1 ES 8206975A1 ES 507400 A ES507400 A ES 507400A ES 507400 A ES507400 A ES 507400A ES 8206975 A1 ES8206975 A1 ES 8206975A1
Authority
ES
Spain
Prior art keywords
preparation
blood coagulation
coagulation factors
peparation
saccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES507400A
Other languages
English (en)
Other versions
ES507400A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES8206975A1 publication Critical patent/ES8206975A1/es
Publication of ES507400A0 publication Critical patent/ES507400A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCEDIMIENTO PARA LA PRODUCCION DE UN PREPARADO DE LOS FACTORES DE COAGULACION DE SANGRE IX Y-O X. SE MEZCLA UNA SOLUCION QUE CONTIENE FACTOR IX Y-O FACTOR X, PREFERIBLENTE UNA FRACCION DE PLASMA O PLACENTA, CON UNA SAL CALCICA SOLUBLE, TAL COMO CLORURO CALCICO O ACETATO CALCICO, EN UNA CONCENTRACION DE 0,4 A 0,6 MOLES POR LITRO Y EVENTUALMENTE CON 1 A 3 MILILITROS POR LITRO DE AL MENOS UN AMINOACIDO, TAL COMO GLICINA, Y 20 A 60 POR 100 EN PESO DE UN MONOSACARIDO, OLIGOSACARIDO O AZUCARALCOHOL, TAL COMO SACAROSA. SE CALIENTA A UNA TEMPERATURA ENTRE 60 Y 100 GRADOS CENTIGRADOS DURANTE, UN TIEMPO ALREDEDOR DE 10 HORAS, MANTENIENDO UN VALOR DE PH DE 6,5 A 8,0. EL PREPARADO SE UTILIZA POR VIA INTRAVENOSA, PREFERIBLEMENTE EN FORMA DE INFUSION, PARA LA TERAPIA Y PROFILAXIS DE HEMORRAGIAS CAUSADAS POR DEFICIT DE FACTOR IX Y-O DE FACTOR X.
ES507400A 1980-11-29 1981-11-24 Procedimiento para la produccion de un preparado, practica- mente seguro frente a hepatitis,de los factores de coagula- cion de sange ix y-o x. Granted ES507400A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803045153 DE3045153A1 (de) 1980-11-29 1980-11-29 Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x

Publications (2)

Publication Number Publication Date
ES8206975A1 true ES8206975A1 (es) 1982-09-01
ES507400A0 ES507400A0 (es) 1982-09-01

Family

ID=6117972

Family Applications (1)

Application Number Title Priority Date Filing Date
ES507400A Granted ES507400A0 (es) 1980-11-29 1981-11-24 Procedimiento para la produccion de un preparado, practica- mente seguro frente a hepatitis,de los factores de coagula- cion de sange ix y-o x.

Country Status (10)

Country Link
US (1) US4405603A (es)
EP (1) EP0053338B1 (es)
JP (1) JPS57120524A (es)
AT (1) ATE11640T1 (es)
AU (1) AU544157B2 (es)
CA (1) CA1182047A (es)
DE (2) DE3045153A1 (es)
ES (1) ES507400A0 (es)
IL (1) IL64396A (es)
MX (1) MX6947E (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
DE3230849A1 (de) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
EP0124506B1 (de) * 1983-05-02 1988-08-17 IMMUNO Aktiengesellschaft für chemisch-medizinische Produkte Verfahren zur Inaktivierung von vermehrungsfähigen Krankheitserregern
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
DE3330770A1 (de) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von humanplasma
US4615886A (en) * 1983-08-31 1986-10-07 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
JPS6094917A (ja) * 1983-10-28 1985-05-28 Green Cross Corp:The Ｂ型肝炎感染予防用ワクチンの製造方法
US4490361A (en) * 1983-12-02 1984-12-25 Alpha Therapeutic Corporation Virus inactivating heat treatment of plasma fractions
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US5171569A (en) * 1985-03-15 1992-12-15 National Research Development Corporation Factor IX preparations uncontaminated by plasma components or pox virus
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
IL86417A (en) * 1987-05-22 1992-09-06 Armour Pharma Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
WO1989005652A1 (en) * 1987-12-21 1989-06-29 American National Red Cross Pure factor ix product
DE4001451A1 (de) * 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
FR2664165B1 (fr) * 1990-07-03 1992-10-16 Lille Transfusion Sanguine Composition pour stabiliser le plasma sanguin en cours de pasteurisation.
JP3418621B2 (ja) * 1991-03-01 2003-06-23 アヴェンティス ベーリング エルエルシー Ｉｘ因子の調製
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
FR2687317B1 (fr) * 1992-02-13 1995-06-23 Aetsrn Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique.
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
EP0674531A1 (de) * 1992-12-16 1995-10-04 IMMUNO Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
US6372716B1 (en) * 1994-04-26 2002-04-16 Genetics Institute, Inc. Formulations for factor IX
US5770700A (en) * 1996-01-25 1998-06-23 Genetics Institute, Inc. Liquid factor IX formulations
EP1010852A1 (en) 1998-12-15 2000-06-21 Schlegel BVBA Sealing gasket and method of making and inserting the same
GB0521139D0 (en) 2005-10-18 2005-11-23 Univ Sheffield Therapeutic agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081432A (en) * 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human

Also Published As

Publication number Publication date
IL64396A (en) 1985-02-28
AU7795081A (en) 1982-06-10
JPS57120524A (en) 1982-07-27
DE3045153A1 (de) 1982-07-08
EP0053338B1 (de) 1985-02-06
US4405603A (en) 1983-09-20
CA1182047A (en) 1985-02-05
JPH0348171B2 (es) 1991-07-23
EP0053338A2 (de) 1982-06-09
IL64396A0 (en) 1982-02-28
MX6947E (es) 1986-12-19
AU544157B2 (en) 1985-05-16
DE3168834D1 (en) 1985-03-21
EP0053338A3 (en) 1982-08-04
ES507400A0 (es) 1982-09-01
ATE11640T1 (de) 1985-02-15

Similar Documents

Publication Publication Date Title
ES8206975A1 (es) Procedimiento para la produccion de un preparado, practica- mente seguro frente a hepatitis,de los factores de coagula- cion de sange ix y-o x.
ES8305213A1 (es) Procedimiento para produccion de un preparado a base de protombina y-o procomuertina.
DE3162578D1 (en) Process for heat treatment of aqueous solution containing human blood coagulation factor xiii
ES8506983A1 (es) Procedimiento para la preparacion de un producto lactoserico
ES461918A1 (es) Un procedimiento para la obtencion de un preparado fomenta- dor de la coagulacion de la sangre a base de plasma sangui- neo humano.
HUT39466A (en) Process for preparing blood coagulation inhibiting proteins
DE3565683D1 (en) Process for preparing copolymers of vinylphosphonic acid and (meth)acrylic acid in an aqueous solution, and their use
DE3173537D1 (en) Permselective fluoropolymeric membrane and method of its production
HUP9901551A2 (hu) Daganatnövekedést gátló készítmények, eljárás előállításukra, és alkalmazásuk
DE3165600D1 (en) Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions
ES8303442A1 (es) "procedimiento para la preparacion de plasminogeno practicamente exento de virus de hepatitis".
GB2077739B (en) Process for isolation of proteins using food grade salt solutions at specified ph and ionic strength
ATE33620T1 (de) Wasserloesliche zusammensetzungen zur herstellung analytischer loesungen.
SU690068A1 (ru) Способ получени спирта-сырца, виннокислой извести и корма из отходов винодельческой промышленности дрожжевых осадков
JPS56104672A (en) Method of sterilizing blood purifier
GB1492441A (en) Confirming a desired heat effect on a material
SU1238290A1 (ru) Способ получения препарата для лечения желудочно-кишечных заболеваний
BG27488A1 (en) Method for determining of blood alcohol concentration
BG31902A1 (en) Method for radioimunological determination of progestron in blood serum
JPS5580748A (en) Method of delaying coagulation of gypsum or gypsummwater glass mixture

Legal Events

Date Code Title Description
PC1A Transfer granted